| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL (INSERM) Patent applications |
| Patent application number | Title | Published |
| 20120114596 | TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES - It relates to the treatment or prevention of a chronic viral infection with a Thymic Stromal Lymphopoietin (TSLP) antagonist thereby avoiding immune evasion and persistence of the virus. It also provides a method of prognosing the evolution of a cervical dysplasia by TSLP expression in a sample of said cervical dysplasia. | 05-10-2012 |
| 20100240033 | CONSTITUTIVELY ACTIVE MUTANTS OF THE PROLACTIN RECEPTOR - The invention relates to constitutively active mutants of the prolactin receptor (PRLR), wherein an Ile residue at position 76 or at position 146 of the mature form of said receptor has been substituted by another amino acid residue. The invention also provides methods useful for the diagnosis, prognosis, or treatment of diseases involving the PRLR. | 09-23-2010 |
| 20100167957 | METHODS FOR PRODUCING ACTIVE SCFV ANTIBODIES AND LIBRARIES THEREFOR - The present disclosure describes scFv antibody libraries, antibodies isolated from the libraries, and methods of producing and using the same. | 07-01-2010 |
| 20090202622 | VIROSOME-LIKE VESICLES COMPRISING GP41-DERIVED ANTIGENS - The present invention relates to a virosome-like vesicle comprising at least a gp41-derived antigen or an analogue thereof, said gp41-derived antigen being located to the external surface of and/or encapsulated inside said vesicle and being in a convenient configuration for conferring said virosome-like vesicle with an ability to induce an immune response against a gp41 protein or a human immunodeficiency virus (HIV). | 08-13-2009 |
| 20090017073 | Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof - A method for modulating Nod1 activity wherein said method comprises the steps of providing cells expressing a functional Nod1: and bringing said cells into contact with a molecule related to compositions comprising a molecule related to MTP and use of a molecule related to MTP for modulating inflammation and/or apoptosis. | 01-15-2009 |